Presently, David H. Mason occupies the position of Chief Medical Officer at MiMedx Group, Inc.

He previously was SVP-Clinical Development & Regulatory Affairs at Sarepta Therapeutics, Inc., Chief Medical Officer & Senior Vice President at Diversity Imaging Ltd., Vice President-Clinical Development at UCB Pharma, Inc. and Director-Clinical Research & Medical Affairs at Ciba-Geigy Pharmaceuticals.

Dr. Mason received an undergraduate degree from Williams College and a doctorate from Duke University School of Medicine.